Drug Database
Back to search

Netherlands· NL-6c1ab5b2aa15

Levosimendan Eureco-Pharma 2,5 mg/ml, concentraat voor oplossing voor infusie

A levosimendan product containing levosimendan, registered in Netherlands by Eureco-Pharma B.V.. The same ATC class is registered in 14 of our 19 countries.

ATC C01CX08

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedLevosimendan Eureco-Pharma 2,5 mg/ml,…ATCC01CX08REGISTER NO.NL-6c1ab5b2aa15PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about levosimendanAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Levosimendan is registered in 14 of 19 countries.

Countries holding a registration under ATC C01CX08 (levosimendan), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 8 of them publish a price we can compare per daily dose
Search levosimendan products by name

Levosimendan · ATC C01CX08

14 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
LEVOSIMENDAN
Manufacturer
Eureco-Pharma B.V.
Country
Netherlands (NL)
ATC code
C01CX08
ATC class
Levosimendan
Defined daily dose
11 mg, P
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    135569//127812

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Levosimendan in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All levosimendan products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Cordenova, Levosimendan Accord
  • Belgium · Levosimendan Kabi, Levosimendan Kalceks
  • Bulgaria · Левосимендан Калцекс, Симдакс
  • Cyprus · Levosimendan Win Medica, Simdax
  • Czechia · Levosimendan Fmk, Levosimendan Kalceks
  • Germany · Levosimendan Accord, Levosimendan Altan
  • Denmark · Levosimendan, Levosimendan Amdipharm
  • Estonia · Levosimendan Auxilia, Levosimendan Kalceks
  • Spain · Levosimendán Accord, Levosimendán Altan
  • Finland · Levosimendan Amdipharm, Levosimendan Bioglan
  • France · Levosimendan Accord, Levosimendan Altan
  • Greece · Levosimendan Win Medica, Simdax
  • Croatia · Levosimendan Alpha-Medical, Levosimendan Kalceks
  • Hungary · Levosimendan Kalceks, Levosimendan Stada
  • Ireland · Levosimendan Kalceks
  • Iceland · Levosimendan Stada, Simdax
  • Italy · Levosimendan Accord, Levosimendan Altan
  • Lithuania · Levosimendan Kalceks
  • Latvia · Levosimendan Kalceks
  • Norway · Levosimendan Amdipharm, Levosimendan Bioglan
  • Poland · Levosimendan Accord, Levosimendan Farmak
  • Portugal · Levossimendano Accord, Levossimendano Altan
  • Romania · Levatrop, Levosimendan
  • Sweden · Levosimendan Amdipharm, Levosimendan Bioglan
  • Slovenia · Levosimendan Carinopharm, Levosimendan Kalceks
  • Slovakia · Levosimendan Fmk, Levosimendan Kalceks

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/baeb4d68-64ad-4206-acd9-2ca5f4573682
GET /v1/drugs/baeb4d68-64ad-4206-acd9-2ca5f4573682?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Concentraat voor oplossing voor infusie",
  "route": "Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h127812_smpc.pdf",
  "strength": null,
  "atc_label": "Levosimendan",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg135569",
  "excipients": [
    "CITROENZUUR 0-WATER (E 330)",
    "ETHANOL",
    "POVIDON (E 1201)"
  ],
  "substances": [
    "LEVOSIMENDAN"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h135569.pdf",
  "authorised_at": "2025/11/03",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "135569//127812",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about levosimendan.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console